Clinical Trials Logo

Ureteral Obstruction clinical trials

View clinical trials related to Ureteral Obstruction.

Filter by:

NCT ID: NCT05265936 Not yet recruiting - Kidney Stone Clinical Trials

Is it Safe to Advance a Guidewire Through a Previously Placed Double j Stent?

Start date: March 2022
Phase: N/A
Study type: Interventional

In this prospective randomized controlled study, it is aimed to investigate the effects of guidewire advanced through a previously placed double j stent on postoperative complications, operation time and efficacy.

NCT ID: NCT05022199 Enrolling by invitation - Clinical trials for Ureteral Obstruction

Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Ureteroenteric anastomotic stricture is a well-known complication of urinary diversion which occurs in 4-25% of patients. Recent study has yielded that radiation is a significant risk factor for development of ureteroenteric stricture. The goal of this study is to determine whether intraoperative use of SPY fluorescent angiography during urinary diversion reduces rate of ureteroenteric stricture. This study will include 215 patients who have undergone urinary diversion over the past 5 years as historic controls and compare ureteroenteric stricture rates to a prospective cohort of patients in whom intraoperative SPY fluorescent angiography was used at the time of urinary diversion to assess the anastomotic perfusion. This will include injection of ICG intravenously as well as utilization of the SPY device to assess ureteral perfusion before and after ureteroenteric anastomosis. Based on power analysis, this study will require approximately 50 patients in our prospective group to detect a clinically significant difference of 5% between groups. Data analysis plan includes the use of chi square test for comparison of stricture rates between groups. Clinical outcomes will be followed prospectively, with no amendment to standard follow-up per physician.

NCT ID: NCT04980079 Recruiting - Ureter Obstruction Clinical Trials

Primary Versus Deferred Ureteroscopy for Calculus Anuria in Children

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

To evaluate the role of both primary and deferred URS in the management of calculus anuria concerning the feasibility, clinical outcome, and cost-effectiveness in children in a comparative study

NCT ID: NCT04884945 Terminated - Clinical trials for Ureteropelvic Junction Obstruction

Pediatric Robotic Versus Open Pyeloplasty

Start date: October 24, 2017
Phase: N/A
Study type: Interventional

The objective is conduct a pilot randomized controlled trial comparing robotic and open techniques for surgical correction of congenital UPJ obstruction (pyeloplasty) in pediatric patients. This study will serve as a proof of concept trial to demonstrate feasibility of recruiting pediatric patients to participate in a randomized study for surgical procedures and delineate patient-centered outcomes. Should this study prove randomization is feasible, a randomized comparative effectiveness trial with sufficient power to determine whether open or robotic-assisted pyeloplasty has superior patient-centered outcomes will be pursued.

NCT ID: NCT04695951 Completed - Urolithiasis Clinical Trials

Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract

Start date: August 1, 2019
Phase: Phase 2
Study type: Interventional

Given the high recurrence of urolithiasis in patients, the search for less aggressive and preventive treatments is increasingly necessary. Renalof® is presented as an alternative to herbal medicine being a product that, due to its diuretic and demineralization properties of kidney stones, has been widely used in this patient population, disintegrating and eliminating calcium oxalate and struvite stones in a painless in the genitourinary system. With the objective of determining the efficacy of this therapy, an observational, prospective, randomized, single-blind, two-arm study was carried out: treatment group with Renalof® and control group, placebo.

NCT ID: NCT04594161 Completed - Kidney Diseases Clinical Trials

Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

STONE
Start date: July 15, 2020
Phase: N/A
Study type: Interventional

To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis.

NCT ID: NCT04197583 Completed - Ureter Obstruction Clinical Trials

Double-J PLUS Postmarket Registry

Start date: February 19, 2020
Phase:
Study type: Observational [Patient Registry]

A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

NCT ID: NCT03709992 Suspended - Quality of Life Clinical Trials

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Start date: December 18, 2020
Phase: N/A
Study type: Interventional

This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.

NCT ID: NCT03266770 Completed - Clinical trials for Ureteral Obstruction

The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position

Start date: June 15, 2021
Phase: N/A
Study type: Interventional

Traditional ureteral stents are commonly used in renal and ureteral procedures, and their use is associated with many morbidities which can affect patients' quality of life. However, replacement of the distal portion of the stent with a thin material may reduce bladder irritative symptoms and allow the ureterovesical junction to coapt---thereby, reducing urinary reflux. The hypothesis is that the RELIEF stent will offer the same function of traditional ureteral stents with the added benefits of minimizing urinary reflux and reducing irritative bladder symptoms.

NCT ID: NCT02812212 Recruiting - Clinical trials for Ureteropelvic Junction Obstruction

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

JUMP
Start date: November 28, 2017
Phase: N/A
Study type: Interventional

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome